Literature DB >> 19803950

Hyperthyroidism during pregnancy: etiology, diagnosis and management.

John H Lazarus1.   

Abstract

Pregnancy has marked effects on thyroid physiology and autoimmune thyroid disease tends to ameliorate through gestation due to the general immunosuppression seen in pregnancy. There is a need for trimester-specific thyroid hormone reference ranges. Hyperthyroidism in pregnancy - usually due to Graves' disease - is not common but, if the patient is compliant, a good outcome can be expected for both mother and child if treatment with anti-thyroid drugs (propylthiouracil is preferred) is instituted. Thyroid-stimulating hormone receptor antibody should be measured at 36 weeks in such patients in order to predict the possibility of neonatal hyperthyroidism. Transient gestational hyperthyroidism is often associated with hyperemesis gravidarum and thyroid function should be checked in patients severely affected by this condition. Radioiodine therapy is contraindicated in pregnancy but thyroid surgery may be performed safely in the second trimester. Autoimmune thyroiditis and Graves' hyperthyroidism occur quite commonly in postpartum women.

Entities:  

Year:  2005        PMID: 19803950     DOI: 10.2217/17455057.1.1.97

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  3 in total

Review 1.  Hyperthyroidism and pregnancy.

Authors:  Helen Marx; Pina Amin; John H Lazarus
Journal:  BMJ       Date:  2008-03-22

2.  Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.

Authors:  Sayid Shafi Zuhur; Alper Ozel; Selvinaz Velet; Mehmet Sait Buğdacı; Esra Cil; Yüksel Altuntas
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 3.  Impending thyroid storm in a pregnant woman with undiagnosed hyperthyroidism: A case report and literature review.

Authors:  Yushan Ma; Hao Li; Jin Liu; Xuemei Lin; Hui Liu
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.